Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

IEX

IDEX Corp. Increases Share Repurchase Authorization to $1 Billion

IDEX Corporation (NYSE: IEX) has announced a significant increase in its share repurchase authorization, bringing the total capacity to $1 billion from approximately $440 million remaining as of June 30, 2025. This move reflects the company's confidence in its growth strategy and ability to consistently generate strong free cash flow.

For the full year 2025, IDEX Corporation expects to return at least 70% of free cash flow to shareholders through dividends and share repurchases. This highlights the company's commitment to shareholder value and its intention to take a dynamic approach to capital allocation.

The company's president and CEO, Eric D. Ashleman, emphasized that in the first half of 2025 alone, IDEX Corporation has accelerated its buyback activity, repurchasing over $100 million. This indicates a proactive approach to capital deployment and returning value to shareholders.

In addition to the share repurchase authorization, the board approved a regular quarterly cash dividend of $0.71 per common share, representing the company's 124th consecutive regular quarterly cash dividend payment. This demonstrates IDEX Corporation's commitment to rewarding shareholders through consistent dividend payments.

It's important to note that the newly announced increase in the share repurchase authorization does not obligate the company to repurchase any specific amount or number of shares of common stock, and the authorization may be suspended or discontinued at any time.

As a result of these announcements, the company's shares have moved -0.81% on the market, and are now trading at a price of $160.75. For the full picture, make sure to review IDEX CORP /DE/'s 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS